Covington Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $121K | Sell |
176
-25
| -12% | -$17.2K | 0.01% | 427 |
|
|
2022
Q2 | $119K | Sell |
201
-806
| -80% | -$477K | ﹤0.01% | 434 |
|
|
2022
Q1 | $704K | Buy |
1,007
+762
| +311% | +$533K | 0.03% | 269 |
|
|
2021
Q4 | $155K | Hold |
245
| – | – | 0.01% | 388 |
|
|
2021
Q3 | $148K | Buy |
245
+1
| +0.4% | +$604 | 0.01% | 383 |
|
|
2021
Q2 | $136K | Buy |
244
+243
| +24,300% | +$135K | 0.01% | 402 |
|
|
2021
Q1 | $0 | Buy |
+1
| New | – | ﹤0.01% | 876 |
|
|
2020
Q2 | – | Sell |
-65
| Closed | -$32K | – | 789 |
|
|
2020
Q1 | $32K | Buy |
65
+55
| +550% | +$27.1K | ﹤0.01% | 472 |
|
|
2019
Q4 | $4K | Buy |
+10
| New | +$4K | ﹤0.01% | 815 |
|
|
2018
Q1 | – | Sell |
-101
| Closed | -$38K | – | 779 |
|
|
2017
Q4 | $38K | Buy |
101
+13
| +15% | +$4.89K | ﹤0.01% | 487 |
|
|
2017
Q3 | $39K | Buy |
+88
| New | +$39K | ﹤0.01% | 462 |
|